Piper Sandler Initiates Coverage On Labcorp Holdings with Neutral Rating, Announces Price Target of $235
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler has initiated coverage on Labcorp Holdings with a Neutral rating and set a price target of $235.
October 01, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Piper Sandler has initiated coverage on Labcorp Holdings with a Neutral rating and a price target of $235, indicating a balanced view on the stock's potential.
The Neutral rating suggests that Piper Sandler does not expect significant short-term price movement for Labcorp Holdings. The price target of $235 provides a benchmark for investors, but the neutral stance indicates no strong buy or sell recommendation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100